| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 04/21/2000 | CA2287139A1 Method for treating congestive heart failure |
| 04/21/2000 | CA2287122A1 Treatment of bph with cgmp elevators |
| 04/20/2000 | WO2000023431A1 Method for the preparation of citalopram |
| 04/20/2000 | WO2000022142A2 Cell signaling polypeptides and nucleic acids |
| 04/20/2000 | WO2000022121A2 Ion channels, in particular vanilloid receptor-like (vr-l) receptor |
| 04/20/2000 | WO2000022120A1 (mbp1) polypeptides capable of interacting with oncogenic mutants of the p53 protein |
| 04/20/2000 | WO2000022113A1 ENZYMATIC SYNTHESIS OF ssDNA |
| 04/20/2000 | WO2000022094A2 Methods for inhibiting oxidative modification of proteins |
| 04/20/2000 | WO2000022008A1 Polymer combining with phosphoric acid and preparation containing the same |
| 04/20/2000 | WO2000021998A1 Bone morphogenetic protein antagonist based on the mature protein |
| 04/20/2000 | WO2000021986A2 Matrix-remodeling genes |
| 04/20/2000 | WO2000021977A1 Pregnane glucuronides |
| 04/20/2000 | WO2000021976A1 Bone morphogenic protein-induced genes and polypeptides, and their use in diagnostic and therapeutic methods |
| 04/20/2000 | WO2000021967A1 Functionalized silicon compounds, their synthesis and use |
| 04/20/2000 | WO2000021964A1 Imidazo-benzazepines having cardiovascular, antitumor, antiinfective and anfiinflammatory activity |
| 04/20/2000 | WO2000021963A1 Il-8 receptor antagonists |
| 04/20/2000 | WO2000021961A1 Imidazo-isoquinoline compounds, their compositions and uses |
| 04/20/2000 | WO2000021960A1 Heterocyclyl amino methyloxa zolidinones as antibacterials |
| 04/20/2000 | WO2000021959A1 4,5-dihydro-isoxazole derivatives and their pharmaceutical use |
| 04/20/2000 | WO2000021956A1 New crystalline modification of 5-fluoro-1-(tetrahydro-2-furyl)-uracyl, and complex compounds based on this modification and having an antitumoral activity |
| 04/20/2000 | WO2000021955A1 Quinazoline derivatives |
| 04/20/2000 | WO2000021954A1 Novel heterocyclyl-methyl-substituted pyrazoles |
| 04/20/2000 | WO2000021953A1 Aryl-{4-fluoro-4-[(2-pyridin-2-yl-ethylamino)-methyl]-piperidin-1-yl}-methanone derivatives as 5-ht1 receptor antagonists |
| 04/20/2000 | WO2000021952A1 Quinoline derivatives and their use as antibacterial agents |
| 04/20/2000 | WO2000021951A1 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 04/20/2000 | WO2000021950A1 2,3-dihydro-1h-isoindole derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 04/20/2000 | WO2000021948A1 Naphthrydine compounds and their azaisosteric analogues as antibacterials |
| 04/20/2000 | WO2000021947A1 Benzazine derivatives as phosphodiesterase 4 inhibitors |
| 04/20/2000 | WO2000021946A1 3-phenyl-pyrones |
| 04/20/2000 | WO2000021942A1 Azadioxacycloalkene derivatives, methods for the production thereof and their use as fungicides and pest control agents |
| 04/20/2000 | WO2000021932A1 NEW PROCESSES FOR PRODUCING β-ALANINE DERIVATIVE |
| 04/20/2000 | WO2000021931A1 Ureidopiperidine derivatives as selective human nk3 receptor antagonists |
| 04/20/2000 | WO2000021930A1 Esters of (+)-alpha-( 2,3- dimethoxyphenyl) -1-[2-(4- fluorophenyl) ethyl]-4- piperidinemethanol and their use as prodrugs of the 5ht2a receptor antagonist mdl 110,907 |
| 04/20/2000 | WO2000021927A2 Pyrrole-2,5-diones as gsk-3 inhibitors |
| 04/20/2000 | WO2000021926A2 6-SUBSTITUTED PYRAZOLO[3,4-d]PYRIMIDIN-4-ONES USEFUL AS CYCLIN DEPENDENT KINASE INHIBITORS |
| 04/20/2000 | WO2000021920A1 Diaminopropionic acid derivatives |
| 04/20/2000 | WO2000021910A2 1,2-disubstituted cyclopropanes |
| 04/20/2000 | WO2000021582A1 Coumarin-based or melilot-based transdermal plasters |
| 04/20/2000 | WO2000021572A2 Hydrogels and water soluble polymeric carriers for drug delivery |
| 04/20/2000 | WO2000021570A1 Combination of norpregnane derivatives and cyclodextrin |
| 04/20/2000 | WO2000021566A1 Sorbefacients and preparations for percutaneous absorption containing the same |
| 04/20/2000 | WO2000021565A1 Selective eradication of virally-infected cells by combined use of a cytotoxic agent and an antiviral agent |
| 04/20/2000 | WO2000021564A1 Composition and method for treating allergic diseases |
| 04/20/2000 | WO2000021563A1 Remedies or preventives for ischemic reflow failure |
| 04/20/2000 | WO2000021562A1 Method to prevent xenograft transplant rejection |
| 04/20/2000 | WO2000021561A1 Model and method for angiogenesis inhibition |
| 04/20/2000 | WO2000021550A2 Methods and compositions for treating neurodegenerative diseases |
| 04/20/2000 | WO2000021549A1 A method of inducing or enhancing chondrogenesis with extracellular matrix containing gdf-5 |
| 04/20/2000 | WO2000021548A2 Angiogenically effective unit dose of fgf and method of administering |
| 04/20/2000 | WO2000021547A2 Utilization of proteolytic enzymes to influence hyperactive t cells |
| 04/20/2000 | WO2000021544A1 Ups (undecaprenyl diphosphate synthase) |
| 04/20/2000 | WO2000021543A1 Method and composition for treating ischemia and sickle cell anemia |
| 04/20/2000 | WO2000021542A1 Methods for stimulating bone formation |
| 04/20/2000 | WO2000021541A1 Process for the preparation of oral pharmaceutical compositions comprising biphosphonates |
| 04/20/2000 | WO2000021540A1 Compositions containing diphosphonic acids |
| 04/20/2000 | WO2000021539A1 Aryldiamine derivatives useful as antibacterial agents |
| 04/20/2000 | WO2000021538A1 A method of modulating ion channel functional activity |
| 04/20/2000 | WO2000021537A1 Novel indenoisoquinolines as antineoplastic agents |
| 04/20/2000 | WO2000021536A1 Prevention and treatment of migraine and other recurrent headaches using leukotriene ltd4 receptor blocker drugs |
| 04/20/2000 | WO2000021535A1 Pharmaceutical formulations for use in estrogen deprivation syndrome |
| 04/20/2000 | WO2000021534A1 Pharmaceutical combination of ibuprofen-lysine and domperidone for treating migraine |
| 04/20/2000 | WO2000021533A1 A dried or frozen pharmaceutical preparation containing a class iii antiarrhythmic compound |
| 04/20/2000 | WO2000021532A1 Methods for inhibiting bone resorption |
| 04/20/2000 | WO2000021531A1 Remedies for ocular diseases |
| 04/20/2000 | WO2000021530A1 Peripherally acting anti-pruritic opiates |
| 04/20/2000 | WO2000021529A1 Methods for prolonging cell membrane permeability |
| 04/20/2000 | WO2000021528A1 Use of ophthalmic composition comprising vitamin a and vitamin e |
| 04/20/2000 | WO2000021527A2 Oxaliplatinum preparation packaging |
| 04/20/2000 | WO2000021526A1 Combination of carnitines and resveratrol for prevention or treatment of cerebral and ageing disorders |
| 04/20/2000 | WO2000021525A2 Sustained release pharmaceutical composition and method of releasing pharmaceutically active agent |
| 04/20/2000 | WO2000021524A1 Pufa supplements |
| 04/20/2000 | WO2000021523A1 Methods for regulating bone formation |
| 04/20/2000 | WO2000021522A1 Use of metformin to counteract weight gain associated with valproate and other psychotropic medications |
| 04/20/2000 | WO2000021521A2 Sertraline oral concentrate |
| 04/20/2000 | WO2000021520A2 Opioid analgesic |
| 04/20/2000 | WO2000021519A1 Drug preparation 'histochrome' for treating acute myocardial infarction and ischaemic heart diseases |
| 04/20/2000 | WO2000021518A1 Drug preparation 'histochrome' for treating ocular conditions |
| 04/20/2000 | WO2000021517A1 Propofol-based anesthetic and method of making same |
| 04/20/2000 | WO2000021516A2 Methods for inhibiting diabetic complications |
| 04/20/2000 | WO2000021515A2 Intranasal codeine for the rapid suppression of cough and rapid relief of pain |
| 04/20/2000 | WO2000021514A2 Method and composition for treating and preventing tuberculosis |
| 04/20/2000 | WO2000021513A2 Methods for treating multiple sclerosis |
| 04/20/2000 | WO2000021512A2 Composition and method for treating allergic diseases |
| 04/20/2000 | WO2000021511A2 Subcutaneous medroxyprogesterone acetate for treatment of menopause and endometriosis |
| 04/20/2000 | WO2000021510A2 Formulations of fexofenadine |
| 04/20/2000 | WO2000021509A2 Methods of treatment |
| 04/20/2000 | WO2000021508A2 Novel therapeutic use of compounds with beta-3-agonist activity |
| 04/20/2000 | WO2000021507A2 Pharmaceutically active composition |
| 04/20/2000 | WO2000021503A1 Method for preparing a solution for nasal spray containing sex hormones and a cyclodextrin |
| 04/20/2000 | WO2000021492A2 Cream cleanser with high levels of emollients and glycerin |
| 04/20/2000 | WO2000021490A1 Use of nanoscale sterols and sterol esters |
| 04/20/2000 | WO2000021487A2 Formoterol polymorphs |
| 04/20/2000 | WO2000021486A2 Prevention of uv-induced functional vitamin a deficiency through use of topically applied retinoid |
| 04/20/2000 | WO2000021371A1 Oral combination of lufenuron and nitenpyram against fleas |
| 04/20/2000 | WO2000021370A1 Oligonucleotide delivery systems for camptothecins |
| 04/20/2000 | WO2000021369A1 Treating hiv with edta |
| 04/20/2000 | WO2000021368A1 Hydroxystilbene compounds used as microbicidal active substances |
| 04/20/2000 | WO2000006605A9 Heterominibodies |
| 04/20/2000 | WO2000004866A3 Preparation of thioarabinofuranosyl compounds and use thereof |
| 04/20/2000 | WO2000004023A9 Anhydride modified cantharidin analogues useful in the treatment of cancer |